DNA vaccines for the prevention and treatment of allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 1, 2009, Pages 50-54

  Chua, Kaw Yan ^a   Kuo, L Chun ^a   Huang, Chiung Hui ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adjuvants; Dendritic cells; DNA vaccine; Immunogenicity; Replicon

Indexed keywords

CYTOKINE; DENDRITIC CELL VACCINE; DNA VACCINE; FASCIN; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; PLACEBO; PLASMID DNA; PROTEIN AIMP1; PROTEIN SERINE THREONINE KINASE; PROTEIN TBK1; UBIQUITIN; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN EXPRESSION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ENZYME REGULATION; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; IMMUNITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPLICON; REVIEW; SKIN ALLERGY; TH2 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANIMALS; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; PROTEIN-SERINE-THREONINE KINASES; REPLICON; VACCINES, DNA;

EID: 58849099045     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283207ad8     Document Type: Review

References (33)

1. Weiss R, Scheiblhofer S, Gabler M, et al. Is genetic vaccination against allergy possible? Int Arch Allergy Immunol 2006; 139:332-345.
2. Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 2008; 7:175-191. A review of recent DNA vaccine clinical studies with emphasis on immunogenicity of DNA vaccines in humans.
3. Fraser CK, Diener KR, Brown MP, Hayball JD. Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 2007; 6: 559-578.
4. Tsen S-WD, Paik AH, Hung C-F, Wu TC. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev Vaccines 2007; 6:227-239. A review on dendritic cell-based strategies to optimize DNA vaccine-elicited immune responses.
5. Klostermann B, Bellinghausen I, Bottcher I, et al. Modification of the human allergic immune response by allergen-DNA-transfected dendritic cells in vitro. J Allergy Clin Immunol 2004; 113:327-333.
6. K̈nig B, Petersen A, Bellinghausen I, et al. Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro. Immunology 2007; 122:239-246. This study showed that allergen gene-transfected human dendritic cells could redirect Th2 to Th1/Tc1 responses at T and B cell levels.
7. Ross R, Sudowe S, Beisner J, et al. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther 2003; 10:1035-1040.
8. Sudowe S, Ludwig-Portugall I, Montermann E, et al. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Mol Ther 2003; 8:567-575.
9. Sudowe S, Ludwig-Portugall I, Montermann E, et al. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J Allergy Clin Immunol 2006; 117:196-203.
10. Zindler E, Gehrke N, Luft C, et al. Divergent effects of biolistic gene transfer in a mouse model of allergic airway inflammation. Am J Respir Cell Mol Biol 2008; 38:38-46.
11. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003; 101:4862-4869.
12. + regulatory T cells. Scand J Immunol 2008; 67:140-151. This study showed that allergen gene-transfected immature dendritic cells could induce T regulatory cells to downregulate established Th2-allergic responses.
13. Jin H, Kang Y, Zhao L, et al. Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines. J Immunol 2008; 180:5360-5372. This study suggested that coimmunization of DNA and protein vaccines approach induced a subset of antiallergic T regulatory cells possibly through a mechanism that involved tolerogenic dendritic cells.
14. Lee BC, O'Sullivan I, Kim E, et al. A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell- mediated immune responses in antigen-sensitized mice. Immunology. doi:10.1111/j.1365-2567.2008.02880.x (in press). This study described a promising strategy to downregulate established Th2 allergic responses using a novel genetic adjuvant.
15. Kim E, Kim SH, Kim S, Kim TS. The novel cytokine p43 induces IL-12 production in macrophages via NF-κB activation, leading to enhance IFN-γ production in CD4+ T cells. J Immunol 2006; 176:256-264.
16. Kim E, Kim SH, Kim S, Cho D, Kim TS. AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability. J Immunol 2008; 180:2894-2902.
17. Takatsu K, Kariyone A. The immunogenic peptide for Th1 development. Int Immunopharmacol 2003; 3:783-800.
18. Mori H, Yamanaka K, Matsuo K, et al. Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. Arch Dermatol Res. doi:10.1007/s00403-008-0873-y (in press).
19. Tan LK, Huang C-H, Kuo IC, et al. Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production. Vaccine 2006; 24:5762-5771.
20. HuangFu T, Lim LH, Chua KY. Efficacy evaluation of Der p 1 DNA vaccine for allergic asthma in an experimental mouse model. Vaccine 2006; 24:4576- 4581.
21. Bauer R, Scheiblhofer S, Kern K, et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 2006; 118:269-276.
22. Slater JE, Paupore E, Zhang YT, Colberg-Poley AM. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J Allergy Clin Immunol 1998; 102:469-475.
23. Scheiblhofer S, Stoecklinger A, Gruber C, et al. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Mol Immunol 2007; 44:1879 - 1887. This comparative study clearly indicated that delivery of conventional plasmid- based DNA vaccines by gene gun immunization induced undesirable Th2 sensitization in vaccinated mice.
24. Leitner WW, Hwang LN, deVeer MJ, et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 2003; 9:33-39.
25. Dubensky TW Jr, Driver DA, Polo JM, et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 1996; 70:508-519.
26. Scheiblhofer S, Gabler M, Leitner WW, et al. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines. Allergy 2006; 61:828-835.
27. Gabler M, Scheiblhofer S, Kern K, et al. Immunization with a low-dose replicon DNA vaccine encoding Phi p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 2006; 118:734-741.
28. Li ML, Stollar V. Alphaviruses and apoptosis. Int Rev Immunol 2004; 23:7- 24.
29. Kaufman RJ. Double-stranded RNA-activated protein kinase mediates virus- induced apoptosis: a new role for an old actor. Proc Natl Acad Sci USA 1999; 96:11693-11695.
30. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22. This review summarized the recently identified cytoplasmic RNA sensors and their signaling pathways to induce the production of antiviral type I IFNs and proinflammatory cytokines.
31. Ishii KJ, Kawagoe T, Koyama S, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008; 451:725-729. This is a groundbreaking research revealing that TANK-binding kinase 1 (TBK1) mediates the adjuvant effect of DNA vaccines and is essential for its immunogenicity in mice.
32. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501 - 505. This study showed the first time that DAI was a cytoplasmic DNA sensor and activated the innate immune response through TBK1 and IRF3.
33. Wang Z, Choi MK, Ban T, et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 2008; 105:5477-5482. This study showed the molecular mechanisms for DAI activation and regulatory mechanisms for cytoplasmic DNA induced innate immunity.